How Topical Diclofenac (Voltaren) Works
Topical diclofenac works primarily through local anti-inflammatory action at the application site, with minimal systemic absorption—achieving only 6% of the systemic exposure compared to oral diclofenac, making it predominantly a local treatment. 1
Mechanism of Action
Diclofenac inhibits cyclooxygenase (COX) enzymes, blocking the arachidonic acid cascade and reducing prostaglandin synthesis, which produces anti-inflammatory, analgesic, and antipyretic effects. 1 While the exact mechanism for treating conditions like actinic keratosis remains unclear, it likely relates to COX pathway inhibition leading to reduced prostaglandin E2 synthesis. 2
Beyond simple COX inhibition, diclofenac demonstrates multimodal mechanisms including inhibition of thromboxane-prostanoid receptors, effects on arachidonic acid metabolism, lipoxygenase enzyme inhibition, and activation of nitric oxide-cGMP pathways. 3 However, these additional mechanisms are primarily relevant to systemic exposure.
Local vs. Systemic Effect
Predominantly Local Action
The effect is overwhelmingly local rather than systemic. The pharmacokinetic data clearly demonstrates this:
- Systemic exposure (AUC) with topical diclofenac gel applied to one knee (4g four times daily) is 17-fold lower than oral diclofenac 1
- Peak plasma concentrations are 158-fold lower with topical versus oral administration 1
- Only 6% of diclofenac applied topically achieves systemic absorption 1
Tissue Penetration Evidence
Topical diclofenac penetrates skin and permeates to deeper tissues in therapeutically relevant concentrations. 4 Studies show the drug preferentially distributes to target tissues with sustained levels over several hours, achieving a lower plasma-to-tissue ratio compared to oral administration. 5, 4 This tissue distribution pattern supports local therapeutic action at the site of application.
Systemic Effects Are Minimal
Topical diclofenac does not inhibit platelet aggregation and produces significantly less COX-1 and COX-2 inhibition systemically compared to oral diclofenac. 6 In a crossover study of 40 healthy volunteers, oral diclofenac inhibited platelet aggregation while topical formulations did not, confirming minimal systemic pharmacodynamic effects. 6
Clinical Implications
The predominantly local mechanism translates to a superior safety profile compared to oral NSAIDs:
- Topical diclofenac causes primarily mild, local skin reactions (application site irritation in approximately 4% for acute conditions, 14% for chronic conditions) 7, 8
- Gastrointestinal adverse events are substantially lower than oral NSAIDs 9, 10
- In a real-world study of 521,593 patients followed for nearly one year, 74.2% experienced no adverse events 8
Important Caveat
Heat application following gel application has not been studied and is not recommended, as it may alter absorption characteristics. 1 However, moderate heat applied before gel application or moderate exercise after application does not clinically alter systemic absorption. 1
For conditions affecting multiple joints or large surface areas, systemic pharmacological treatment may be more practical than topical application. 10 The local nature of topical diclofenac makes it most suitable for localized musculoskeletal conditions, osteoarthritis of accessible joints (knees, hands), or dermatologic conditions like actinic keratosis where field treatment of limited areas is appropriate. 2, 10